Taking in consideration the bystander effects of articular senescence

Affiliations

Editorial

Jean-Marc Brondello et al. Ann Transl Med. 2019 Dec.

. 2019 Dec;7(Suppl 8):S386.

doi: 10.21037/atm.2019.12.128.

¹ IRMB, University of Montpellier, Inserm U1183, CHU Montpellier, Montpellier, France.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Intraarticular senescent chondrocytes impair the cartilage regeneration capacity of mesenchymal stem cells.
Cao X, Luo P, Huang J, Liang C, He J, Wang Z, Shan D, Peng C, Wu S. Cao X, et al. Stem Cell Res Ther. 2019 Mar 12;10(1):86. doi: 10.1186/s13287-019-1193-1. Stem Cell Res Ther. 2019. PMID: 30867061 Free PMC article.

1. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014;73:1323-30. 10.1136/annrheumdis-2013-204763 - DOI - PubMed
1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96. 10.1016/S0140-6736(12)61729-2 - DOI - PMC - PubMed
1. Martel-Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis. Nat Rev Dis Prim 2016;2:16072. 10.1038/nrdp.2016.72 - DOI - PubMed
1. He S, Sharpless NE. Senescence in Health and Disease. Cell 2017;169:1000-11. 10.1016/j.cell.2017.05.015 - DOI - PMC - PubMed
1. Tachikart Y, Malaise O, Mumme M, et al. Seno-suppressive molecules as new therapeutic perspectives in rheumatic diseases. Biochem Pharmacol 2019;165:126-33. 10.1016/j.bcp.2019.03.017 - DOI - PubMed